Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
Avezum
A
A
Division of Cardiology, McMaster University, Hamilton General Hospital, Ontario, Canada.
Pais
P
P
Flather
M D
MD
Anand
S
S
Yusuf
S
S
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents